CR

Chirag Ranjitbhai Kapadia

Active Director Director DIN 11688788
DIN 11688788 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Chirag Ranjitbhai Kapadia

Data last updated:

Chirag Ranjitbhai Kapadia is a Director at Curious Biotech Private Limited (since 2026).

DIN 11688788
Primary Designation Director
First Appointment 04 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curious Biotech Private Limited U20237GJ2026PTC177420
Director04 May 20262026Active

Board colleagues of Chirag Ranjitbhai Kapadia

Directorship timeline

Open interactive timeline →
Curious Biotech Private Limited
Premium access

Shareholding and investment profile for Chirag Ranjitbhai Kapadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Ranjitbhai Kapadia

Chirag Ranjitbhai Kapadia currently holds 1 directorship: Curious Biotech Private Limited (Director, since 04 May 2026).

Chirag Ranjitbhai Kapadia was first appointed on 04 May 2026 as Director at Curious Biotech Private Limited.

The current boards of Chirag Ranjitbhai Kapadia's companies include Hardik Jawaharbhai Mehta (Curious Biotech Private Limited), Kinnariben U Desai (Curious Biotech Private Limited), Priya Vishal Ganatra (Curious Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available